Ye Xu

2.4k total citations
90 papers, 1.7k citations indexed

About

Ye Xu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ye Xu has authored 90 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 33 papers in Oncology and 33 papers in Cancer Research. Recurrent topics in Ye Xu's work include BRCA gene mutations in cancer (20 papers), DNA Repair Mechanisms (14 papers) and Cancer Genomics and Diagnostics (13 papers). Ye Xu is often cited by papers focused on BRCA gene mutations in cancer (20 papers), DNA Repair Mechanisms (14 papers) and Cancer Genomics and Diagnostics (13 papers). Ye Xu collaborates with scholars based in China, Ethiopia and United States. Ye Xu's co-authors include Yuntao Xie, Zhaoqing Fan, Benyao Lin, Tao Ouyang, Jinfeng Li, Tie Fan, Tianfeng Wang, Tao Ouyang, Bairong Xia and Bo Lin and has published in prestigious journals such as Nature, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ye Xu

89 papers receiving 1.6k citations

Peers

Ye Xu

ONCOL

GENET

PRM

E. Berns Netherlands

Sengül Tozlu France

Michaela J. Higgins United States

Susan E. Bray United Kingdom

Sten Wingren Sweden

Maria Luisa Veronese United States

Valentina Calò Italy

Eiichiro Tominaga Japan

Rutger Meinsma Netherlands

Josh Lauring United States

E. Berns Netherlands

Ye Xu

1.0k ×1.1

763 ×1.1

921 ×1.6

ONCOL

488 ×1.3

GENET

168 ×0.9

PRM

Citations per year, relative to Ye Xu Ye Xu (= 1×) peers E. Berns

Countries citing papers authored by Ye Xu

Since Specialization

Citations

This map shows the geographic impact of Ye Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Xu more than expected).

Fields of papers citing papers by Ye Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Xu. The network helps show where Ye Xu may publish in the future.

Co-authorship network of co-authors of Ye Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Xu. A scholar is included among the top collaborators of Ye Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Xu. Ye Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Tong, et al.. (2024). Histone deacetylase inhibitor and PD‑1 blockade synergistically inhibit B‑cell lymphoma progression in mice model by promoting T‑cell infiltration and apoptosis. Oncology Reports. 52(4). 1 indexed citations

Liu, Xuejing, Yanjie Wang, Kun Cao, et al.. (2023). Impact of multifocal or multicentric disease on local recurrence and survival in breast cancer patients with or without BRCA1/2 variants. Breast Cancer Research and Treatment. 199(1). 25–33. 3 indexed citations

Deng, Cong, Chaozeng Si, Ye Xu, et al.. (2021). Prognostic significance of FSCN family in multiple myeloma. Journal of Cancer. 12(7). 1936–1944. 2 indexed citations

Liu, Hanqing, Ye Xu, Lei Tang, et al.. (2019). Improving The Oral Absorption Of Nintedanib By A Self-Microemulsion Drug Delivery System: Preparation And In Vitro/In Vivo Evaluation. SHILAP Revista de lepidopterología. 1 indexed citations

Xu, Ye, Lu Yao, Tao Ouyang, et al.. (2019). Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer. International Journal of Cancer. 146(2). 487–495. 17 indexed citations

Chen, Xinyi, Tao Ouyang, Jinfeng Li, et al.. (2019). Co-mutation of TP53 and PIK3CA in residual disease after neoadjuvant chemotherapy is associated with poor survival in breast cancer. Journal of Cancer Research and Clinical Oncology. 145(5). 1235–1242. 14 indexed citations

Xu, Ye, Tao Ouyang, Jinfeng Li, et al.. (2017). HER2 Pro1170Ala polymorphism is associated with decreased survival rate in HER2-negative breast cancer. Oncology Letters. 13(5). 3793–3798. 2 indexed citations

Xu, Ye, et al.. (2016). Comprehensive study of mutational and clinicopathologic characteristics of adenocarcinoma with lepidic pattern in surgical resected lung adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 143(1). 181–186. 4 indexed citations

Liu, Tianbo, et al.. (2015). Increased NUCKS expression is a risk factor for poor prognosis and recurrence in endometrial cancer.. PubMed Central. 5(12). 3659–67. 12 indexed citations

10.

Sun, Jie, Yuxia Wang, Yisui Xia, et al.. (2015). Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer. PLoS Genetics. 11(5). e1005228–e1005228. 73 indexed citations

11.

Xu, Ye, Tao Ouyang, Zhaoqing Fan, et al.. (2014). Association between the HER2 Ile655Val polymorphism and response to trastuzumab in women with operable primary breast cancer. Annals of Oncology. 25(6). 1158–1164. 37 indexed citations

12.

Wu, Peng, et al.. (2014). Down-regulated MYH11 Expression Correlates with Poor Prognosis in Stage II and III Colorectal Cancer. Asian Pacific Journal of Cancer Prevention. 15(17). 7223–7228. 30 indexed citations

13.

Xu, Ye, Wei Yan, Tao Ouyang, et al.. (2013). Association of SIPA1 545 C > T polymorphism with survival in Chinese women with metastatic breast cancer. Frontiers of Medicine. 7(1). 138–142. 8 indexed citations

14.

Zhang, Pengfei, Gu‐Qing Zeng, Rong Hu, et al.. (2012). Identification of Flotillin-1 as a novel biomarker for lymph node metastasis and prognosis of lung adenocarcinoma by quantitative plasma membrane proteome analysis. Journal of Proteomics. 77. 202–214. 31 indexed citations

15.

Liu, Yin, Ji Liao, Ye Xu, et al.. (2011). A recurrent CHEK2 p.H371Y mutation is associated with breast cancer risk in Chinese women. Human Mutation. 32(9). 1000–1003. 22 indexed citations

16.

Xu, Ye, et al.. (2010). Study on the relation between TCM syndrome and metabolic syndrome of overweight and obesity patients.. Zhongguo zhongyiyao xinxi zazhi. 17(11). 15–17. 1 indexed citations

17.

Yin, Mingzhu, Ye Xu, Ge Lou, et al.. (2010). LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis. International Journal of Cancer. 129(3). 629–635. 37 indexed citations

18.

Lu, Jiade J., et al.. (2009). Standardized pelvic drainage of anastomotic leaks following anterior resection without diversional stomas. The American Journal of Surgery. 199(6). 753–758. 15 indexed citations

19.

Chen, Yanglin, Jing Zhou, Ye Xu, et al.. (2009). BRCA1 promoter methylation associated with poor survival in Chinese patients with sporadic breast cancer. Cancer Science. 100(9). 1663–1667. 28 indexed citations

20.

Li, Hongxia, Ye Xu, Tao Ouyang, et al.. (2006). The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women. Acta Oncologica. 45(5). 597–601. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact